Format

Send to

Choose Destination
See comment in PubMed Commons below
Lancet. 1989 Jul 15;2(8655):122-4.

Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia.

Author information

  • 1Department of Human Biopathology, University La Sapienza, Rome, Italy.

Abstract

In a double-blind study, 12 consecutive patients with acute promyelocytic leukaemia were randomised either to tranexamic acid (TA group) or to placebo (control group) for 6 days to see whether inhibition of fibrinolysis would reduce haemorrhage and transfusion requirements. The total study period was 14 days. In the TA group, there were fewer haemorrhagic episodes, as determined by a scoring system. Packed red cell transfusion requirements decreased; and fewer additional platelet concentrate transfusions were needed. These beneficial effects were more pronounced in the second week. There were no thromboembolic complications.

PMID:
2567893
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk